NCT05403307 - A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil | Biotech Hunter

Enrollment

757

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

July 17, 2023

Conditions

COVID-19

Interventions

BIOLOGICAL

Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine

BIOLOGICAL

CoronaVac COVID-19 vaccine

Trial Locations (5)

Jardim Coopagro, Toledo

Jardim Cosmos primary healthcare unit, Toledo

Jardim Maracanã, Toledo

Jardim Porto Alegre, Toledo

Pediatric Emergency Service, Toledo